CAR T細胞とCAR NK細胞による標的外効果の差異は,細胞治療の効果と安全性の違いを示唆する
Katharina Schindler-Wnek1, Anika Stahringer1, Nadine Heimer1,2
1Department for Cell and Gene Therapy Development, Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.
Oncoimmunology
|September 5, 2025
まとめ
化学抗原受容体 (CAR) のNK細胞は,特定の標的に対するCAR T細胞の有効性と一致する,がん免疫療法において有望である. 独特の調節により 副作用が軽減され より広範な抗原標的化により がん治療が改善されます
科学分野:
- 免疫学
- 腫瘍学
- バイオテクノロジー
背景:
- 化学抗原受容体 (CAR) ベースの細胞治療は,腫瘍学における臨床的有効性を示しています.
- CAR T細胞治療は確立されており,CAR NK細胞治療は臨床開発の初期段階にある.
- 腫瘍内および腫瘍外での毒性は,健康な組織に共通する腫瘍関連抗原による課題です.
研究 の 目的:
- 多発性骨髄腫関連抗原 (BCMA,SLAMF7,CD38) に対するCAR T細胞とCAR NK細胞の活性を比較的に分析する.
- CARNK細胞の活性化と細胞毒性に対する抗原密度の影響を調査する.
- CARNK細胞が標的外効果を軽減する可能性を評価する.
主な方法:
- CAR T細胞とCAR NK細胞の比較分析
- 異なる抗原発現を持つ標的細胞に対する細胞活性化と細胞毒性の評価
- CAR NK細胞機能における抑制受容体 (KIR,NKG2A) の役割の評価
主要な成果:
- CAR NK細胞の細胞毒性は,BCMAとCD38に対するCAR T細胞と同等であった.
- SLAMF7に誘導されたCAR細胞では,有効性の違いが観察されました.
- CARNK細胞の活性が抑制受容体によって調節され,腫瘍制御と潜在的腫瘍外毒性をバランスさせました.
結論:
- CAR NK細胞は,特定の標的に対して,CAR T細胞と同様の細胞毒性を有する.
- CARNK細胞における阻害受容体シグナリングは,標的外効果を緩和するメカニズムを提供します.
- CARNK細胞は,がん免疫療法における標的抗原選択の柔軟性を高めています.
関連する概念動画
01:27Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K